Evaluation of topical oclacitinib and nail trimming as a treatment for murine ulcerative dermatitis in laboratory mice
Murine ulcerative dermatitis (UD) is a common, multifactorial skin disease of C57BL/6 and C57BL/6-background strains of mice. Many treatment options have been previously reported but have been variably successful and may interfere with specific research studies. Janus kinase (JAK) inhibitors, such a...
Main Authors: | Steven E. Davison, Kathryn M. Emmer, Beatrice Ugiliweneza, Leslie C. Sherwood |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578627/?tool=EBI |
Similar Items
-
Evaluation of topical oclacitinib and nail trimming as a treatment for murine ulcerative dermatitis in laboratory mice.
by: Steven E Davison, et al.
Published: (2022-01-01) -
Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib
by: Kennedy Mwacalimba, et al.
Published: (2023-09-01) -
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
by: Marike Visser, et al.
Published: (2022-03-01) -
A "Pedi" Cures All: Toenail Trimming and the Treatment of Ulcerative Dermatitis in Mice.
by: Sean C Adams, et al.
Published: (2016-01-01) -
The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
by: Hester Rynhoud, et al.
Published: (2021-02-01)